A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

Condition:   Acute Ischemic Stroke Interventions:   Drug: LT3001 Drug Product;   Drug: Placebo Sponsor:   Lumosa Therapeutics Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - September 17, 2019 Category: Research Source Type: clinical trials